While apCAFs isolated from orthotopic mouse tumor models were shown to induce lymphocyte activation, as measured by CD25 and CD69 upregulation, in an antigen specific manner, apCAFs express low levels of costimulatory molecules CD80, CD86 and CD40 when compared to professional antigen presenting cells (Elyada et al., 2019). This evidence concerns the gene CD40 and neoplasm.